Rongjian Su

874 total citations
27 papers, 654 citations indexed

About

Rongjian Su is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Rongjian Su has authored 27 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Rongjian Su's work include Cancer-related gene regulation (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Cancer Mechanisms and Therapy (4 papers). Rongjian Su is often cited by papers focused on Cancer-related gene regulation (6 papers), Nanoparticle-Based Drug Delivery (5 papers) and Cancer Mechanisms and Therapy (4 papers). Rongjian Su collaborates with scholars based in China, Japan and United States. Rongjian Su's co-authors include Hongdan Li, Liang Zhao, Hua‐chuan Zheng, Chang Su, Liwei Liu, Shuang Zhao, Huijuan Song, Xuefeng Yang, Song Zhao and Hongzhi Sun and has published in prestigious journals such as Scientific Reports, International Journal of Pharmaceutics and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Rongjian Su

26 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongjian Su China 16 410 146 125 101 101 27 654
Heba Alshaker United Kingdom 16 487 1.2× 120 0.8× 149 1.2× 55 0.5× 157 1.6× 24 733
Suqin Shen China 15 521 1.3× 109 0.7× 121 1.0× 46 0.5× 171 1.7× 41 761
Young Mi Whang South Korea 16 381 0.9× 64 0.4× 153 1.2× 38 0.4× 93 0.9× 35 627
Arnab Ghosh United States 18 445 1.1× 96 0.7× 201 1.6× 73 0.7× 183 1.8× 27 746
Sourav Banerjee United Kingdom 16 653 1.6× 177 1.2× 180 1.4× 26 0.3× 105 1.0× 33 973
Wei‐Dong Lü China 14 303 0.7× 47 0.3× 184 1.5× 93 0.9× 160 1.6× 32 731
Vanessa Moreno Spain 10 360 0.9× 63 0.4× 120 1.0× 31 0.3× 116 1.1× 10 668
Zixi Wang China 14 328 0.8× 36 0.2× 89 0.7× 49 0.5× 85 0.8× 31 656
Se Jin Oh South Korea 15 359 0.9× 54 0.4× 190 1.5× 54 0.5× 70 0.7× 22 601
Chi‐Hung Tzang Hong Kong 11 359 0.9× 80 0.5× 129 1.0× 23 0.2× 131 1.3× 13 718

Countries citing papers authored by Rongjian Su

Since Specialization
Citations

This map shows the geographic impact of Rongjian Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongjian Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongjian Su more than expected).

Fields of papers citing papers by Rongjian Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongjian Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongjian Su. The network helps show where Rongjian Su may publish in the future.

Co-authorship network of co-authors of Rongjian Su

This figure shows the co-authorship network connecting the top 25 collaborators of Rongjian Su. A scholar is included among the top collaborators of Rongjian Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongjian Su. Rongjian Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tian, Yuan, et al.. (2024). Design, synthesis, and antitumor activities of novel ureido/thioureido derivatives with a 4-phenylthiazol-2-amine scaffold. Journal of Saudi Chemical Society. 28(4). 101900–101900.
3.
4.
Yang, Panpan, Qin Zhou, Xiaoqi Zhang, et al.. (2022). Notum leads to potential pro-survival of OSCC through crosstalk between Shh and Wnt/β-catenin signaling via p-GSK3β. The International Journal of Biochemistry & Cell Biology. 153. 106316–106316. 7 indexed citations
5.
Berges, Bradford K., et al.. (2021). Artesunate Regulates Neurite Outgrowth Inhibitor Protein B Receptor to Overcome Resistance to Sorafenib in Hepatocellular Carcinoma Cells. Frontiers in Pharmacology. 12. 615889–615889. 18 indexed citations
6.
Liu, Shanshan, Qin Zhou, Rongjian Su, et al.. (2021). As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma. International Journal of Biological Sciences. 18(2). 491–506. 27 indexed citations
7.
8.
Wang, Yue, et al.. (2017). Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells. Oncotarget. 8(12). 19354–19364. 40 indexed citations
9.
Wang, Jingjing, et al.. (2016). Opposite Effects of Two-Derived Antioxidants from Physalis pubescens L. on Hepatocellular Carcinoma Cell Line Malhavu. Current Pharmaceutical Biotechnology. 17(13). 1117–1125. 4 indexed citations
10.
Zhao, Song, Hongdan Li, Qingjun Wang, et al.. (2015). The role of c-Src in the invasion and metastasis of hepatocellular carcinoma cells induced by association of cell surface GRP78 with activated α2M. BMC Cancer. 15(1). 389–389. 33 indexed citations
11.
Su, Rongjian, et al.. (2015). An integrated approach of predicted miR-34a targets identifies a signature for gastric cancer. Oncology Letters. 10(2). 653–660. 5 indexed citations
12.
Li, Hongdan, Liang Zhao, Song Zhao, et al.. (2015). GRP78 confers the resistance to 5-FU by activating the c-Src/LSF/TS Axis in hepatocellular carcinoma. Oncotarget. 6(32). 33658–33674. 23 indexed citations
13.
Su, Chang, Hongdan Li, Yijie Shi, et al.. (2014). Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid. International Journal of Pharmaceutics. 474(1-2). 202–211. 50 indexed citations
14.
15.
Zhao, Liang, Hongdan Li, Yijie Shi, et al.. (2014). Nanoparticles inhibit cancer cell invasion and enhance antitumor efficiency by targeted drug delivery via cell surface-related GRP78. International Journal of Nanomedicine. 10. 245–245. 28 indexed citations
16.
Zhao, Liang, Rongjian Su, Wenyu Cui, et al.. (2014). Preparation of biocompatible heat-labile enterotoxin subunit B-bovine serum albumin nanoparticles for improving tumor-targeted drug delivery via heat-labile enterotoxin subunit B mediation. International Journal of Nanomedicine. 9. 2149–2149. 15 indexed citations
17.
Li, Hongdan, et al.. (2013). Knockdown of FAK inhibits the invasion and metastasis of Tca-8113 cells in vitro. Molecular Medicine Reports. 8(2). 703–707. 15 indexed citations
18.
Li, Hongdan, et al.. (2012). Knockdown of glucose-regulated protein 78 decreases the invasion, metalloproteinase expression and ECM degradation in hepatocellular carcinoma cells. Journal of Experimental & Clinical Cancer Research. 31(1). 39–39. 39 indexed citations
19.
Su, Rongjian, Zhen Li, Hongdan Li, et al.. (2010). Grp78 promotes the invasion of hepatocellular carcinoma. BMC Cancer. 10(1). 20–20. 85 indexed citations
20.
Zhao, Min, Hongxin Wang, Jing Yang, et al.. (2007). δ‐OPIOID RECEPTOR STIMULATION ENHANCES THE GROWTH OF NEONATAL RAT VENTRICULAR MYOCYTES VIA THE EXTRACELLULAR SIGNAL‐REGULATED KINASE PATHWAY. Clinical and Experimental Pharmacology and Physiology. 35(1). 97–102. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heba Alshaker Breakdown of academic impact, for papers by Suqin Shen Breakdown of academic impact, for papers by Young Mi Whang Breakdown of academic impact, for papers by Arnab Ghosh Breakdown of academic impact, for papers by Sourav Banerjee Breakdown of academic impact, for papers by Wei‐Dong Lü Breakdown of academic impact, for papers by Vanessa Moreno Breakdown of academic impact, for papers by Zixi Wang Breakdown of academic impact, for papers by Se Jin Oh Breakdown of academic impact, for papers by Chi‐Hung Tzang
Rankless by CCL
2026